Application of Computer Aided Drug Design methods and CADD directed AI/ML in lead identification & optimization, in silico studies on ADME/T prediction, design of PTP1B inhibitors, CCR2 agents, PKC-beta2 inhibitors, ALR2 inhibitors, Neuramidase inhibitors, Enoyl reductase inhibitors.